Samir Sinha

Contributor

Dr. Samir Sinha is Director of Health Policy Research at the National Institute of Ageing; Director of Geriatrics at Sinai Health and University Health Network; and Professor of Medicine, Family and Community Medicine, Health Policy, Management and Evaluation at the University of Toronto. During his career, Dr. Sinha has also served as a consultant or adviser for influenza and other vaccine manufacturers in Canada, including CSL Seqirus, GSK, Moderna, Pfizer and Sanofi.

1 Contribution
by Samir Sinha

New flu vaccination guidance boosts protection for our most vulnerable

We should put all efforts into achieving our 80 per cent goal of getting older Canadians better protected against the more serious and deadly consequences of influenza in a more cost-effective way.

1 of 1